世界の次世代シークエンシング（NGS）市場...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 24)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 33)

3 Market Overview (Page No. – 38)
3.1 Introduction
3.2 Evolution
3.3 Market Segmentation
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Cost and Speed to Drive the Growth of NGS Technology
3.4.1.2 Substitution of Microarray Technology by NGS to Boost Market Growth
3.4.1.3 Embracement of NGS Technology by New Consumers to Propel the Market
3.4.1.4 Increase in Practice for New Scientific Applications to Boost the Growth
3.4.1.5 Research Laboratories and Academicians Promoting the Use of NGS
3.4.2 Restraints
3.4.2.1 High Reliability on Grants to Restrict Growth
3.4.2.2 Decrease in Capital Expenditure from Academic Institutes to Hinder the Sale of Platforms
3.4.2.3 Accuracy & Standardization, a Concern in Diagnostic Testing
3.4.3 Opportunities
3.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for Investments in NGS Technology
3.4.3.2 Pre-sequencing, a High Growth Opportunity
3.4.3.3 Cloud Computing, a Prospective Service
3.4.4 Challenges
3.4.4.1 Interpretation of Complex Data from NGS Platforms
3.4.4.2 Designing of Sequencers as the Breadth of NGS Applications Increase
3.4.5 Market Trend
3.4.5.1 Shift of Focus Towards Third Generation Sequencing
3.4.6 Burning Issues
3.4.6.1 Data Storage, an Impediment for NGS Sequencing
3.4.6.2 Reduction in Cost to Sequence Human Genomes
3.4.7 Winning Imperative
3.4.7.1 Improved Collaborative Ties Between Industry and Academic & Research Institutes
3.5 Porter’s Five Forces Analysis
3.5.1 Threat From New Entrants
3.5.2 Threat From Substitutes
3.5.3 Bargaining Power Of Buyers
3.5.4 Bargaining Power Of Suppliers
3.5.5 Competitive Rivalry Among Exisiting Firms
3.6 Value Chain
3.7 Technological Development Road-Map
3.7.1 Sanger Sequencing
3.7.2 Massively Parallel Sequencing (Next Generation Sequencing)
3.7.3 Single Molecule Real Time (SMRT) Sequencing
3.7.4 Nanopore Sequencing
3.8 Technological Trends
3.8.1 Nanopore Sequencing Technology
3.8.1.1 Oxford Nanopore Technologies
3.8.1.2 Genia Technologies
3.8.1.3 Electronic Biosciences
3.8.2 Sequencing By Hybridization Technology (GNUBIO)
3.8.3 GENIUS (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (GENAPSYS)
3.8.4 Lightning Terminator Sequencing Technology (LASERGEN)
3.8.5 Optical Nanopore Sequencing Technology (NOBLEGEN)
3.8.6 Nanowire Biosensor Sequencing Technology (QUANTUMDX)
3.9 End-User Analysis
3.9.1 Introduction
3.9.2 Research Centers, Academic & Government Institutes
3.9.2.1 NGS is a Research Driven Market, Hence the Highest Market Share
3.9.3 Hospitals & Clinics
3.9.3.1 Hospitals and Clinics to Grow at the Fastest Rate
3.9.4 Pharmaceutical & Biotechnology Companies
3.9.4.1 Targeted Therapy and Biomarker Research to Boost the Pharmaceutical & Biotechnology NGS Market
3.9.5 Others
3.10 Market Share Analysis
3.10.1 Total Ngs Market
3.10.1.1 Global
3.10.1.2 North America
3.10.1.3 Europe
3.10.1.4 Asia
3.10.2 NGS Platform Market
3.10.2.1 Global
3.10.2.2 North America
3.10.2.3 Europe
3.10.2.4 Asia
3.10.3 NGS Bioinformatics/Data Analysis Market
3.10.3.1 Global

4 Global Ngs Market, By Steps In Workflow (Page No. – 78)
4.1 Introduction
4.2 Pre-Sequencing Products & Services Market
4.2.1 Sample Preparation
4.2.1.1 Dna Fragmentation, End Repair, A-Tailing And Size Selection
4.2.1.2 Library Preparation
4.2.1.3 Target Enrichment
4.2.1.4 Quality Control
4.3 Sequencing Platforms Market
4.3.1 Illumina
4.3.1.1 Hiseq Series
4.3.1.2 Genome Analyzer IIx
4.3.1.2.1 No Technological Advancements Will Result Into Downfall Of GA IIx
4.3.1.3 HiScanSQ
4.3.1.4 MiSeq
4.3.1.4.1 MiSeq will grow at the fastest pace amongst all the platforms
4.3.2 Life Technologies
4.3.2.1 SOLiD Series
4.3.2.1.1 Solid Series Shows Minimal Scope For Growth
4.3.2.2 Ion Torrent Platforms
4.3.2.2.1 Ion PGM
4.3.2.2.1.1 Currently Ion PGM exceeds the unit sales as compared to its competitors
4.3.2.2.2 Ion Proton
4.3.2.2.2.1 Ion Proton will be one of the fast growing platforms
4.3.3 454 ROCHE
4.3.3.1 GS Junior and GS FLX+ will Grow at Slow Pace in the Coming Years
4.3.3.2 GS Junior
4.3.3.3 GS FLX+
4.3.4 Pacific Biosciences
4.3.4.1 PacBio RS II
4.3.5 Others
4.4 Sequencing Services Market
4.5 NGS Data Analysis, Storage And Management (Bioinformatics) Market
4.5.1 Open Source Applications Contribute 75% To The Overall Ngs Bioinformatics Solutions
4.5.2 NGS Data Analysis, By Product
4.5.2.1 NGS Data Analysis Software and Workbenches
4.5.2.2 NGS Data Analysis Services
4.5.3 NGS Data Analysis, By Application
4.5.3.1 Whole Genome Sequencing
4.5.3.2 Targeted Re-sequencing
4.5.3.3 DE NOVO Sequencing
4.5.3.4 RNA-Seq
4.5.3.5 CHIP-Seq
4.5.3.6 Methyl-Seq
4.5.3.7 Others
4.5.4 NGS Storage, Management & Cloud Computing Solutions

5 NGS Technology Market (Page No. – 129)
5.1 Introduction
5.2 Sequencing By Synthesis (SBS)
5.2.1 SBS To Be The Fastest-Growing Technology
5.3 ION Semiconductor Sequencing
5.3.1 ION Semiconductor Sequencing, A Fast-Growing Market
5.4 Sequencing By Ligation (SBL)
5.4.1 SBL Technology To Witness Negative Growth
5.5 Pyrosequencing
5.5.1 Pyrosequencing To Grow At Slow Rate
5.6 Single-Molecule Real-Time Sequencing (SMRT)
5.6.1 SMRT Technology Has Limited Applications

6 Global NGS Application Market (Page No. – 141)
6.1 Introduction
6.2 Diagnostics
6.2.1 Diagnostic Market Will Grow With Addition Of Wider Applications
6.2.2 Cancer Diagnostics To Drive the Market
6.3 Drug Discovery
6.3.1 Focus On Targeted Therapy To Boost The Ngs Market
6.4 Biomarker Discovery
6.4.1 Biomarker Discovery Application To Grow At A High Rate
6.5 Personalized Medicine
6.5.1 Personalized Medicine Offers Huge Potential Market
6.6 Agriculture & Animal Research
6.6.1 Applications In Crop Research & Animal Biotechnology To Boost The NGS Market
6.7 Other Applications

7 Geographic Analysis (Page No. -156)
7.1 Introduction
7.2 North America
7.2.1 Funding By Government Agencies To Boost THE U.S. MARKET
7.2.2 Canadian Government Strive To Boost NGS Market
7.3 Europe
7.3.1 Germany Holds The Largest Share Of European NGS Market
7.3.2 U.K. To Contribute Substantially To Europe
7.4 Asia
7.4.1 China & Other Nations Focus On Research In NGS
7.4.2 Regular Funding From Indian Government, An Impetus To The Ngs Market
7.5 Rest Of The World (ROW)

8 Competitive Landscape (Page No. – 186)
8.1 Introduction
8.1.1 New Product Launch & Agreements And Partnerships, Highly Adopted Strategies For Growth
8.2 Mergers & Acquisitions
8.3 Agreements, Partnerships, Collaborations & Joint Ventures
8.4 New Product Launch
8.5 Expansion

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 236)
9.1 454 Life Sciences Corporation (A Roche Company)
9.2 Agilent Technologies, Inc.
9.3 BGI (Beijing Genomics Institute)
9.4 Biomatters, Ltd.
9.5 CLC Bio
9.6 Dnastar, Inc.
9.7 EMC Corporation
9.8 GATC biotech AG
9.9 Genomatix Software GMBH
9.10 Illumina, Inc.
9.11 Knome, Inc.
9.12 Life Technologies Corporation
9.13 Macrogen, Inc.
9.14 Ocimum Biosolutions, Ltd.
9.15 Oxford Nanorpore Technologies, Ltd.
9.16 Pacific Biosciences
9.17 Partek Incorporated
9.18 Perkinelmer, Inc.
9.19 Qiagen N.V.
9.20 Strand Life Sciences Pvt. Ltd.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.